Mark Raffeld
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment 205
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research 93
- Oncology top 0.05%
- Viral-associated cancers and disorders 111
- Immunology top 0.1%
- Immune Cell Function and Interaction 36
- T-cell and Retrovirus Studies 27
- Dermatology top 0.05%
- Cutaneous lymphoproliferative disorders research 37
-
- Eosinophilic Disorders and Syndromes 24
-
- Lung Cancer Treatments and Mutations 24
- Co-authors
- Elaine S. JaffeStefania PittalugaLynn SorbaraES JaffeLiqiang XiSteven A. RosenbergMark E. DudleyMaryalice Stetler‐Stevenson
- Journals
- Blood (88 papers)The American Journal of Surgical Pathology (42 papers)Journal of Clinical Oncology (22 papers)
- Partner nations
- United StatesGermanyMalaysia
In The Last Decade
Mark Raffeld
420 papers receiving 26.8k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Pathology and Forensic Medicine 11.0k
- Genetics 5.5k
- Oncology 14.1k
- Immunology 7.8k
- Dermatology 2.3k
Countries citing papers authored by Mark Raffeld
This map shows the geographic impact of Mark Raffeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Raffeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Raffeld more than expected).
Fields of papers citing papers by Mark Raffeld
This network shows the impact of papers produced by Mark Raffeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Raffeld. The network helps show where Mark Raffeld may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Raffeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 6 | |
| 5 | 2016 | 77 | |
| 6 | 2015 | 141 | |
| 7 | A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Responsebreakdown → | 2014 | 585 |
| 8 | B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myelomabreakdown → | 2013 | 492 |
| 9 | 2012 | 60 | |
| 10 | 2011 | 100 | |
| 11 | 2011 | 133 | |
| 12 | 2011 | 58 | |
| 13 | 2009 | 35 | |
| 14 | 2009 | 36 | |
| 15 | 2009 | 51 | |
| 16 | 2008 | 217 | |
| 17 | 2008 | 221 | |
| 18 | Asparagine synthetase as a causal, predictive biomarker forL-asparaginase activity in ovarian cancer cells | 2007 | 0 |
| 19 | The transcription factor CCAAT/enhancer binding protein (C/EBP)beta is constitutively expressed in ALK-positive anaplastic large cell lymphomas (ALCL), and is dependent upon NPM-ALK kinase activity | 2006 | 1 |
| 20 | Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. | 1998 | 71 |
About Mark Raffeld
Mark Raffeld is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 428 papers that have together received 27.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (205 papers), Viral-associated cancers and disorders (111 papers), Chronic Lymphocytic Leukemia Research (93 papers), Cutaneous lymphoproliferative disorders research (37 papers), Immune Cell Function and Interaction (36 papers), T-cell and Retrovirus Studies (27 papers), Eosinophilic Disorders and Syndromes (24 papers) and Lung Cancer Treatments and Mutations (24 papers). The work is most often cited by research in Pathology and Forensic Medicine (11.0k citations), Genetics (5.5k citations) and Oncology (14.1k citations). Mark Raffeld has collaborated with scholars based in United States, Germany and Malaysia. Frequent co-authors include Elaine S. Jaffe, Stefania Pittaluga, Lynn Sorbara, ES Jaffe, Liqiang Xi, Steven A. Rosenberg, Mark E. Dudley, Maryalice Stetler‐Stevenson, Wyndham H. Wilson and Richard M. Sherry. Their work appears in journals such as Blood, The American Journal of Surgical Pathology, Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.